HEADER IMMUNE SYSTEM 06-JUL-00 1F90 TITLE FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN TITLE 2 INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB FRAGMENT OF MONOCLONAL ANTIBODY; COMPND 3 CHAIN: L; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: FAB FRAGMENT OF MONOCLONAL ANTIBODY; COMPND 6 CHAIN: H; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: ANTIGENIC NONAPEPTIDE; COMPND 9 CHAIN: E; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: HYBRIDOMA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 9 ORGANISM_TAXID: 10090; SOURCE 10 CELL_LINE: HYBRIDOMA; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHETIZED IN SOLUTION KEYWDS MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN-2, KEYWDS 2 ANTIGENIC PEPTIDE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.V.AFONIN,A.V.FOKIN,I.N.TSIGANNIK,I.Y.MIKHAILOVA,L.V.ONOPRIENKO, AUTHOR 2 I.I.MIKHALEVA,V.T.IVANOV,T.Y.MAREEVA,V.A.NESMEYANOV,N.LI,W.L.DUAX, AUTHOR 3 V.Z.PLETNEV REVDAT 6 30-OCT-24 1F90 1 REMARK REVDAT 5 04-APR-18 1F90 1 REMARK REVDAT 4 24-FEB-09 1F90 1 VERSN REVDAT 3 01-APR-03 1F90 1 JRNL REVDAT 2 10-OCT-01 1F90 1 JRNL REVDAT 1 11-JUL-01 1F90 0 JRNL AUTH P.V.AFONIN,A.V.FOKIN,I.N.TSYGANNIK,I.Y.MIKHAILOVA, JRNL AUTH 2 L.V.ONOPRIENKO,I.I.MIKHALEVA,V.T.IVANOV,T.Y.MAREEVA, JRNL AUTH 3 V.A.NESMEYANOV,N.LI,W.A.PANGBORN,W.L.DUAX,V.Z.PLETNEV JRNL TITL CRYSTAL STRUCTURE OF AN ANTI-INTERLEUKIN-2 MONOCLONAL JRNL TITL 2 ANTIBODY FAB COMPLEXED WITH AN ANTIGENIC NONAPEPTIDE. JRNL REF PROTEIN SCI. V. 10 1514 2001 JRNL REFN ISSN 0961-8368 JRNL PMID 11468348 JRNL DOI 10.1110/PS.3101 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.V.FOKIN,P.V.AFONIN,I.Y.MIKHAILOVA,I.N.TSYGANNIK, REMARK 1 AUTH 2 T.Y.MAREEVA,V.A.NESMEYANOV,W.PANGBORN,N.LEE,W.DUAX,E.SIJAK, REMARK 1 AUTH 3 V.Z.PLETNEV REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF ANTIGEN BINDING FRAGMENT OF REMARK 1 TITL 2 MONOCLONAL ANTIBODY AGAINST HUMAN INTERLEUKIN-2 IN TWO REMARK 1 TITL 3 CRYSTAL FORMS AT 2.2 AND 2.9 A RESOLUTION. REMARK 1 REF BIOORG.KHIM. V. 26 571 2000 REMARK 1 REFN ISSN 0132-3423 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 13733 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1212 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3454 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CROSS-VALIDATED MAXIMUM LIKELIHOOD REMARK 3 SIMULATED ANNEALING REFINEMENT (CNS PACKAGE) REMARK 4 REMARK 4 1F90 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-00. REMARK 100 THE DEPOSITION ID IS D_1000011391. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 300.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.4 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.58250 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG-4000, 2-PROPANOL, NA-CITRATE , PH REMARK 280 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.38000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS H 92 CA - CB - SG ANGL. DEV. = 7.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL L 51 -46.40 61.30 REMARK 500 ASP L 151 72.65 44.65 REMARK 500 SER L 153 -1.71 -49.32 REMARK 500 GLU L 154 95.14 -60.69 REMARK 500 ASN L 212 70.37 -179.25 REMARK 500 GLU L 213 -150.39 -169.04 REMARK 500 VAL H 2 -145.08 32.16 REMARK 500 PRO H 14 152.65 -49.69 REMARK 500 SER H 15 -19.36 81.38 REMARK 500 TYR H 33 168.47 74.18 REMARK 500 PRO H 41 89.85 -63.50 REMARK 500 ASN H 43 -3.37 80.62 REMARK 500 ALA H 88 175.62 171.75 REMARK 500 ASP H 97 -3.49 72.91 REMARK 500 SER H 128 -74.86 94.35 REMARK 500 ALA H 129 -130.81 44.24 REMARK 500 PHE H 148 137.08 -170.87 REMARK 500 SER H 180 -85.24 76.13 REMARK 500 ASP H 183 25.97 -156.80 REMARK 500 PRO H 199 -92.02 -55.74 REMARK 500 SER H 203 -76.84 -66.32 REMARK 500 PRO H 227 -161.03 -65.79 REMARK 500 ARG H 228 -44.97 171.04 REMARK 500 ASP H 229 -119.16 50.55 REMARK 500 PRO E 2 151.45 -42.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE OF THE PROTEIN HAS NOT BEEN DEPOSITED IN REMARK 999 ANY SEQUENCE DATABASE. IT WAS PUBLISHED IN THE REMARK 999 BIOORGANICHESKAYA KHIMIYA (RUS) (1995), V21, N6, P430-435. REMARK 999 "CLONING CDNA ENCODING FV-FRAGMENTS OF THE LIGHT AND REMARK 999 HEAVY CHAINS OF THE MONOCLONAL ANTIBODY" BY A.I.PASKHIN, REMARK 999 T.N. GOLOVINA, V.A. NESMEYANOV, V.G. KOROBKO. DBREF 1F90 L 1 214 PDB 1F90 1F90 1 214 DBREF 1F90 H 1 230 PDB 1F90 1F90 1 230 DBREF 1F90 E 1 9 PDB 1F90 1F90 1 9 SEQRES 1 L 219 ASP VAL GLN MET THR GLN THR PRO LEU THR LEU SER VAL SEQRES 2 L 219 THR ILE GLY GLN PRO ALA SER ILE SER CYS GLU SER SER SEQRES 3 L 219 GLN SER LEU LEU TYR SER ASN GLY LYS THR TYR LEU ASN SEQRES 4 L 219 TRP LEU LEU GLN ARG PRO GLY GLN SER PRO LYS ARG LEU SEQRES 5 L 219 ILE TYR LEU VAL SER LYS LEU ASP SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 ARG ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 219 TYR CYS VAL GLN GLY THR HIS PHE PRO ARG THR PHE GLY SEQRES 9 L 219 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 220 GLY VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 H 220 PRO SER GLN SER LEU SER LEU THR CYS THR VAL THR GLY SEQRES 3 H 220 TYR SER ILE THR SER ASP TYR ALA TRP ASN TRP ILE ARG SEQRES 4 H 220 GLN PHE PRO GLY ASN LYS LEU GLU TRP MET GLY TYR ILE SEQRES 5 H 220 THR TYR SER GLY SER THR GLY TYR ASN PRO SER LEU LYS SEQRES 6 H 220 SER ARG ILE SER ILE THR ARG ASP THR SER LYS ASN GLN SEQRES 7 H 220 PHE PHE LEU GLN LEU ASN SER VAL THR THR GLU ASP THR SEQRES 8 H 220 ALA THR TYR TYR CYS ALA SER TYR ASP ASP TYR THR TRP SEQRES 9 H 220 PHE THR TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 220 ALA ALA LYS THR THR PRO PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 220 PRO GLY SER ALA ALA GLN THR ASN SER MET VAL THR LEU SEQRES 12 H 220 GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 220 VAL THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS SEQRES 14 H 220 THR PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SEQRES 15 H 220 SER SER SER VAL THR VAL PRO SER SER PRO ARG PRO SER SEQRES 16 H 220 GLU THR VAL THR CYS ASN VAL ALA HIS PRO ALA SER SER SEQRES 17 H 220 THR LYS VAL ASP LYS LYS ILE VAL PRO ARG ASP CYS SEQRES 1 E 9 LYS PRO LEU GLU GLU VAL LEU ASN LEU FORMUL 4 HOH *89(H2 O) HELIX 1 1 GLU L 79 LEU L 83 5 5 HELIX 2 2 SER L 121 SER L 127 1 7 HELIX 3 3 LYS L 183 GLU L 187 1 5 HELIX 4 4 THR H 83 THR H 87 5 5 HELIX 5 5 SER H 163 SER H 165 5 3 HELIX 6 6 PRO H 213 SER H 216 5 4 HELIX 7 7 PRO E 2 LEU E 7 1 6 SHEET 1 A 4 MET L 4 THR L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 N SER L 22 O THR L 7 SHEET 3 A 4 ASP L 70 ILE L 75 -1 N PHE L 71 O CYS L 23 SHEET 4 A 4 PHE L 62 SER L 67 -1 O THR L 63 N ARG L 74 SHEET 1 B 6 THR L 10 THR L 14 0 SHEET 2 B 6 THR L 102 LYS L 107 1 O LYS L 103 N LEU L 11 SHEET 3 B 6 GLY L 84 GLN L 90 -1 O GLY L 84 N LEU L 104 SHEET 4 B 6 LEU L 33 GLN L 38 -1 N ASN L 34 O VAL L 89 SHEET 5 B 6 LYS L 45 TYR L 49 -1 O LYS L 45 N LEU L 37 SHEET 6 B 6 LYS L 53 LEU L 54 -1 O LYS L 53 N TYR L 49 SHEET 1 C 4 THR L 10 THR L 14 0 SHEET 2 C 4 THR L 102 LYS L 107 1 O LYS L 103 N LEU L 11 SHEET 3 C 4 GLY L 84 GLN L 90 -1 O GLY L 84 N LEU L 104 SHEET 4 C 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 PHE L 139 -1 N VAL L 133 O PHE L 118 SHEET 3 D 4 TYR L 173 THR L 182 -1 N TYR L 173 O PHE L 139 SHEET 4 D 4 VAL L 159 TRP L 163 -1 O LEU L 160 N THR L 178 SHEET 1 E 3 ASN L 145 ILE L 150 0 SHEET 2 E 3 SER L 191 THR L 197 -1 N THR L 193 O LYS L 149 SHEET 3 E 3 ILE L 205 ASN L 210 -1 O ILE L 205 N ALA L 196 SHEET 1 F 4 LEU H 4 SER H 7 0 SHEET 2 F 4 LEU H 18 VAL H 24 -1 N THR H 21 O SER H 7 SHEET 3 F 4 GLN H 77 LEU H 82 -1 O PHE H 78 N CYS H 22 SHEET 4 F 4 ILE H 67 ASP H 72 -1 O SER H 68 N GLN H 81 SHEET 1 G 5 THR H 57 TYR H 59 0 SHEET 2 G 5 LEU H 45 THR H 52 -1 N TYR H 50 O GLY H 58 SHEET 3 G 5 ALA H 34 GLN H 39 -1 N TRP H 35 O ILE H 51 SHEET 4 G 5 ALA H 88 TYR H 95 -1 O THR H 89 N GLN H 39 SHEET 5 G 5 THR H 101 TRP H 103 -1 O TYR H 102 N SER H 94 SHEET 1 H 6 THR H 57 TYR H 59 0 SHEET 2 H 6 LEU H 45 THR H 52 -1 N TYR H 50 O GLY H 58 SHEET 3 H 6 ALA H 34 GLN H 39 -1 N TRP H 35 O ILE H 51 SHEET 4 H 6 ALA H 88 TYR H 95 -1 O THR H 89 N GLN H 39 SHEET 5 H 6 THR H 107 VAL H 111 -1 O THR H 107 N TYR H 90 SHEET 6 H 6 LEU H 11 VAL H 12 1 N VAL H 12 O THR H 110 SHEET 1 I 4 SER H 120 LEU H 124 0 SHEET 2 I 4 MET H 137 TYR H 147 -1 O GLY H 141 N LEU H 124 SHEET 3 I 4 LEU H 184 PRO H 194 -1 N TYR H 185 O TYR H 147 SHEET 4 I 4 VAL H 171 THR H 173 -1 N HIS H 172 O SER H 190 SHEET 1 J 4 SER H 120 LEU H 124 0 SHEET 2 J 4 MET H 137 TYR H 147 -1 O GLY H 141 N LEU H 124 SHEET 3 J 4 LEU H 184 PRO H 194 -1 N TYR H 185 O TYR H 147 SHEET 4 J 4 VAL H 177 GLN H 179 -1 N VAL H 177 O THR H 186 SHEET 1 K 3 THR H 153 TRP H 157 0 SHEET 2 K 3 THR H 207 HIS H 212 -1 N ASN H 209 O THR H 156 SHEET 3 K 3 THR H 217 LYS H 222 -1 O THR H 217 N HIS H 212 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.02 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS L 214 CYS H 230 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 5 CYS H 142 CYS H 208 1555 1555 2.03 CISPEP 1 THR L 7 PRO L 8 0 0.07 CISPEP 2 PHE L 94 PRO L 95 0 -0.13 CISPEP 3 TYR L 140 PRO L 141 0 0.20 CISPEP 4 PHE H 148 PRO H 149 0 -0.19 CISPEP 5 GLU H 150 PRO H 151 0 0.33 CISPEP 6 ARG H 200 PRO H 202 0 -0.04 CRYST1 46.830 72.760 72.150 90.00 106.98 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021354 0.000000 0.006520 0.00000 SCALE2 0.000000 0.013744 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014492 0.00000